JP2018502080A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502080A5 JP2018502080A5 JP2017533387A JP2017533387A JP2018502080A5 JP 2018502080 A5 JP2018502080 A5 JP 2018502080A5 JP 2017533387 A JP2017533387 A JP 2017533387A JP 2017533387 A JP2017533387 A JP 2017533387A JP 2018502080 A5 JP2018502080 A5 JP 2018502080A5
- Authority
- JP
- Japan
- Prior art keywords
- dengue
- vaccine
- composition
- live
- serotype
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462095331P | 2014-12-22 | 2014-12-22 | |
| US62/095,331 | 2014-12-22 | ||
| PCT/US2015/066549 WO2016106107A2 (en) | 2014-12-22 | 2015-12-18 | Dengue virus vaccine compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018502080A JP2018502080A (ja) | 2018-01-25 |
| JP2018502080A5 true JP2018502080A5 (enExample) | 2019-01-31 |
Family
ID=56151628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017533387A Pending JP2018502080A (ja) | 2014-12-22 | 2015-12-18 | デングウイルスワクチン組成物およびその使用方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10449243B2 (enExample) |
| EP (1) | EP3236997B1 (enExample) |
| JP (1) | JP2018502080A (enExample) |
| CN (1) | CN106999568A (enExample) |
| AU (1) | AU2015369875A1 (enExample) |
| BR (1) | BR112017013270A2 (enExample) |
| CL (1) | CL2017001595A1 (enExample) |
| CO (1) | CO2017005830A2 (enExample) |
| CR (1) | CR20170280A (enExample) |
| ES (1) | ES2981476T3 (enExample) |
| MX (1) | MX383329B (enExample) |
| MY (1) | MY192543A (enExample) |
| NI (1) | NI201700080A (enExample) |
| PH (1) | PH12017501165B1 (enExample) |
| SG (1) | SG11201704942QA (enExample) |
| WO (1) | WO2016106107A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170143817A1 (en) * | 2015-11-20 | 2017-05-25 | Oregon Health & Science University | Dengue virus vaccine |
| TWI625393B (zh) * | 2016-11-15 | 2018-06-01 | 國立清華大學 | 對抗複數種登革熱病毒血清型之疫苗套組及其製備方法與用途 |
| BR112020011205A8 (pt) | 2017-12-07 | 2023-02-07 | Merck Sharp & Dohme | Formulações de composições de vacina contra o vírus da dengue |
| WO2020236973A1 (en) * | 2019-05-20 | 2020-11-26 | Soligenix, Inc. | Compositions and methods of manufacturing trivalent filovirus vaccines |
| WO2025027616A1 (en) * | 2023-08-01 | 2025-02-06 | Serum Institute Of India Private Limited | Freeze-dried viral vaccine compositions and method of manufacturing thereof |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6184024B1 (en) | 1988-07-14 | 2001-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric and/or growth-restricted flaviviruses |
| US6190859B1 (en) | 1995-04-17 | 2001-02-20 | The United States Of America As Represented By The Secretary Of The Army | Method and kit for detection of dengue virus |
| US6254873B1 (en) | 1995-04-17 | 2001-07-03 | The United States Of America As Represented By The Secretary Of The Army | Inactivated dengue virus vaccine |
| AU6093296A (en) | 1995-06-07 | 1996-12-30 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Infectious dengue 2 virus pdk-53 as quadravalent vaccine |
| EP0836090A1 (en) | 1996-10-12 | 1998-04-15 | Evotec BioSystems GmbH | Method of analysis of samples by determination of the distribution of specific brightnesses of particles |
| DE69830579T2 (de) | 1997-02-28 | 2006-05-04 | Acambis, Inc., Cambridge | Chimäre impfstoffe gegen flaviviren |
| EP1005363B1 (en) | 1997-07-31 | 2006-03-29 | Hawaii Biotech, Inc. | Recombinant dimeric envelope vaccine against flaviviral infection |
| DE69942525D1 (de) | 1998-09-02 | 2010-08-05 | Us Government | Dengue viren, die in mosquitos nicht replizieren, zur verwendung als impfstoff |
| EP1165127B1 (en) | 1999-03-26 | 2008-12-31 | Walter Reed Army Institute of Research | Multivalent dengue virus vaccine |
| AU4040400A (en) | 1999-03-26 | 2000-10-16 | Walter Reed Army Institute Of Research | Attenuated dengue-4 virus vaccine |
| CA2365728A1 (en) | 1999-03-26 | 2000-10-05 | Walter Reed Army Institute Of Research | Attenuated dengue-1 virus vaccine |
| US6511667B1 (en) | 1999-03-26 | 2003-01-28 | The United States Of America As Represented By The Secretary Of The Army | Attenuated dengue-2 virus vaccine |
| US6432411B1 (en) | 1999-07-13 | 2002-08-13 | Hawaii Biotechnology Group | Recombinant envelope vaccine against flavivirus infection |
| ES2533085T3 (es) | 2001-05-22 | 2015-04-07 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Desarrollo de mutaciones útiles para atenuar virus del dengue y virus del dengue quiméricos |
| US7459160B2 (en) | 2002-01-15 | 2008-12-02 | Acambis Inc. | Chimeric flaviviruses |
| ATE481982T1 (de) | 2002-05-03 | 2010-10-15 | Us Gov Health & Human Serv | Dengue-vakzine mit einer gemeinsamen 30 nukleotid-deletion im 3'-utr der dengue-typen 1 und 2. |
| AU2003239932A1 (en) | 2002-05-31 | 2003-12-19 | Acambis, Inc. | Tetravalent dengue vaccines |
| US7189403B2 (en) | 2003-06-30 | 2007-03-13 | Institut Pasteur | Attenuated flavivirus strains containing a mutated M-ectodomain and their applications |
| CA2549173A1 (en) | 2003-12-08 | 2005-07-07 | Hybridon, Inc. | Modulation of immunostimulatory properties by small oligonucleotide-based compounds |
| JP4993301B2 (ja) | 2004-10-20 | 2012-08-08 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | 日本脳炎ウイルスおよび西ナイルウイルスに対するワクチン |
| JP5197362B2 (ja) | 2005-06-17 | 2013-05-15 | サノフィ・パスツール | デング熱セロタイプ１弱毒株 |
| CA2611954C (en) | 2005-06-17 | 2014-01-28 | Sanofi Pasteur | Dengue serotype 2 attenuated strain |
| EP1896069B1 (en) | 2005-06-24 | 2013-03-13 | Intervet International BV | Inactivated chimeric vaccines and related methods of use |
| CA2616026A1 (en) | 2005-07-22 | 2007-02-08 | Research Development Foundation | Attenuated strains of flaviviruses , and uses thereof |
| US7470674B2 (en) | 2005-11-07 | 2008-12-30 | Idera Pharmaceuticals, Inc. | Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides |
| AR061197A1 (es) | 2006-06-07 | 2008-08-13 | Sanofi Pasteur | Cepas del virus 3 del dengue vivas atenuadas |
| PL2589602T3 (pl) | 2006-08-15 | 2016-11-30 | Rozwinięcie komponentów szczepionki przeciwko wirusowi dengi | |
| FR2906724B1 (fr) | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| EP2086526B1 (en) | 2006-11-09 | 2014-07-23 | The United States Of America As Represented By The Secretary of the Navy | Induction of an immune response against Dengue virus using prime-boost approach |
| US8440202B2 (en) | 2006-11-09 | 2013-05-14 | The United States Of America As Represented By The Secretary Of The Navy | Induction of an immune response against dengue virus using the prime-boost approach |
| BRPI0904020B8 (pt) * | 2009-10-01 | 2021-05-25 | Fundacao Oswaldo Cruz | composição vacinal contra o vírus da dengue, e, kit |
| KR20130138789A (ko) * | 2010-10-29 | 2013-12-19 | 머크 샤프 앤드 돔 코포레이션 | 재조합 서브유닛 뎅기 바이러스 백신 |
| WO2012065105A2 (en) * | 2010-11-12 | 2012-05-18 | Thomas Monath | Chimeric flavivirus vaccines |
| US20150265695A1 (en) * | 2012-07-24 | 2015-09-24 | Sanofi Pasteur | Vaccine compositions for prevention against dengue virus infection |
| WO2014204892A1 (en) * | 2013-06-21 | 2014-12-24 | Merck Sharp & Dohme Corp. | Dengue virus vaccine compositions and methods of use thereof |
-
2015
- 2015-12-18 MY MYPI2017000917A patent/MY192543A/en unknown
- 2015-12-18 JP JP2017533387A patent/JP2018502080A/ja active Pending
- 2015-12-18 US US15/536,319 patent/US10449243B2/en active Active
- 2015-12-18 EP EP15874179.3A patent/EP3236997B1/en active Active
- 2015-12-18 CN CN201580070223.8A patent/CN106999568A/zh active Pending
- 2015-12-18 WO PCT/US2015/066549 patent/WO2016106107A2/en not_active Ceased
- 2015-12-18 AU AU2015369875A patent/AU2015369875A1/en not_active Abandoned
- 2015-12-18 MX MX2017008342A patent/MX383329B/es unknown
- 2015-12-18 CR CR20170280A patent/CR20170280A/es unknown
- 2015-12-18 PH PH1/2017/501165A patent/PH12017501165B1/en unknown
- 2015-12-18 SG SG11201704942QA patent/SG11201704942QA/en unknown
- 2015-12-18 BR BR112017013270A patent/BR112017013270A2/pt not_active Application Discontinuation
- 2015-12-18 ES ES15874179T patent/ES2981476T3/es active Active
-
2017
- 2017-06-14 CO CONC2017/0005830A patent/CO2017005830A2/es unknown
- 2017-06-16 CL CL2017001595A patent/CL2017001595A1/es unknown
- 2017-06-20 NI NI201700080A patent/NI201700080A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013542224A5 (enExample) | ||
| JP2018502080A5 (enExample) | ||
| US11883480B2 (en) | Formulations of dengue virus vaccine compositions | |
| TWI812650B (zh) | 包含特別是減毒活重組黃病毒的穩定疫苗組成物以及製備其的製程 | |
| US9132184B2 (en) | Stabilization of vaccines by lyophilization | |
| Lai et al. | Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus | |
| JP2015535302A (ja) | ビリオン分解に影響を及ぼすフラビウイルスのエンベロープタンパク質変異 | |
| JP2019511221A5 (enExample) | ||
| US9861692B2 (en) | Dengue virus vaccine compositions and methods of use thereof | |
| JP2016504315A5 (enExample) | ||
| JP2019511221A (ja) | 弱毒化された生ジカウイルスワクチン | |
| JP2019509750A (ja) | 生弱毒化アルファウイルス構築物及び方法、ならびにそれらの使用 | |
| ES2981476T3 (es) | Composiciones de vacunas contra el virus del dengue y métodos de uso de las mismas | |
| He et al. | Replication/assembly defective avian flavivirus with internal deletions in the capsid can be used as an approach for living attenuated vaccine | |
| US11123420B2 (en) | Stable live attenuated recombinant dengue vaccine | |
| Park et al. | Strategy for novel vaccine and antivirals against foot-and-mouth disease | |
| TW202507000A (zh) | 冷凍乾燥的病毒之疫苗組合物及其製造方法 |